These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23695514)

  • 1. Diphtheria toxin-based targeted toxin therapy for brain tumors.
    Li YM; Vallera DA; Hall WA
    J Neurooncol; 2013 Sep; 114(2):155-64. PubMed ID: 23695514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted toxins in brain tumor therapy.
    Li YM; Hall WA
    Toxins (Basel); 2010 Nov; 2(11):2645-62. PubMed ID: 22069569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotoxin treatment of brain tumors.
    Hall WA
    Methods Mol Biol; 2001; 166():139-54. PubMed ID: 11217364
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-2 fusion toxin: targeted therapy for cutaneous T cell lymphoma.
    Foss FM
    Ann N Y Acad Sci; 2001 Sep; 941():166-76. PubMed ID: 11594570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotoxins for targeted cancer therapy.
    Kreitman RJ
    AAPS J; 2006 Aug; 8(3):E532-51. PubMed ID: 17025272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies.
    Kreitman RJ
    BioDrugs; 2009; 23(1):1-13. PubMed ID: 19344187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical studies with targeted toxins in malignant glioma.
    Rainov NG; Söling A
    Rev Recent Clin Trials; 2006 May; 1(2):119-31. PubMed ID: 18473963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides.
    Saleh MN; LeMaistre CF; Kuzel TM; Foss F; Platanias LC; Schwartz G; Ratain M; Rook A; Freytes CO; Craig F; Reuben J; Sams MW; Nichols JC
    J Am Acad Dermatol; 1998 Jul; 39(1):63-73. PubMed ID: 9674399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diphtheria toxin conjugate therapy of cancer.
    Frankel AE; Powell BL; Lilly MB
    Cancer Chemother Biol Response Modif; 2002; 20():301-13. PubMed ID: 12703211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial clinical experiences with an interleukin-2 fusion toxin (DAB486-IL-2).
    Meneghetti CM; LeMaistre CF
    Targeted Diagn Ther; 1992; 7():395-401. PubMed ID: 1633301
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunotoxins in cancer therapy.
    Kreitman RJ
    Curr Opin Immunol; 1999 Oct; 11(5):570-8. PubMed ID: 10508704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted toxin therapy for malignant astrocytoma.
    Hall WA
    Neurosurgery; 2000 Mar; 46(3):544-51; discussion 552. PubMed ID: 10719849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials of targeted toxins.
    Frankel AE; Tagge EP; Willingham MC
    Semin Cancer Biol; 1995 Oct; 6(5):307-17. PubMed ID: 8562908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy of cancer using diphtheria toxin-derived immunotoxins.
    Potala S; Sahoo SK; Verma RS
    Drug Discov Today; 2008 Sep; 13(17-18):807-15. PubMed ID: 18678276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials with intracerebral convection-enhanced delivery of targeted toxins in malignant glioma.
    Rainov NG; Gorbatyuk K; Heidecke V
    Rev Recent Clin Trials; 2008 Jan; 3(1):2-9. PubMed ID: 18474010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotoxins in cancer therapy: Review and update.
    Akbari B; Farajnia S; Ahdi Khosroshahi S; Safari F; Yousefi M; Dariushnejad H; Rahbarnia L
    Int Rev Immunol; 2017 Jul; 36(4):207-219. PubMed ID: 28282218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humanized immunotoxins: a new generation of immunotoxins for targeted cancer therapy.
    Mathew M; Verma RS
    Cancer Sci; 2009 Aug; 100(8):1359-65. PubMed ID: 19459847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted anticancer immunotoxins and cytotoxic agents with direct killing moieties.
    Kawakami K; Nakajima O; Morishita R; Nagai R
    ScientificWorldJournal; 2006 Jul; 6():781-90. PubMed ID: 16830050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hosts and Heterologous Expression Strategies of Recombinant Toxins for Therapeutic Purposes.
    di Leandro L; Colasante M; Pitari G; Ippoliti R
    Toxins (Basel); 2023 Dec; 15(12):. PubMed ID: 38133203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotoxins.
    Kreitman RJ
    Expert Opin Pharmacother; 2000 Sep; 1(6):1117-29. PubMed ID: 11249483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.